NEW YORK – The Centers for Medicare & Medicaid Services, after listening to stakeholders' concerns, has proposed a new national coverage policy for germline next-generation sequencing panels for cancer patients, removing previously suggested restrictions around testing early-stage patients.
To read the full story....
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.